
Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Fundamental Analysis


Revenue & Expenses Breakdown
Mind Medicine (MindMed) Inc
Balance Sheet Decomposition
Mind Medicine (MindMed) Inc
Current Assets | 221.7m |
Cash & Short-Term Investments | 212.4m |
Other Current Assets | 9.3m |
Non-Current Assets | 53.6m |
Long-Term Investments | 33.1m |
Intangibles | 19.9m |
Other Non-Current Assets | 606k |
Free Cash Flow Analysis
Mind Medicine (MindMed) Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Mind Medicine (MindMed) Inc
Revenue
|
0
USD
|
Operating Expenses
|
-111.3m
USD
|
Operating Income
|
-111.3m
USD
|
Other Expenses
|
33.7m
USD
|
Net Income
|
-77.6m
USD
|
MNMD Profitability Score
Profitability Due Diligence
Mind Medicine (MindMed) Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Score
Mind Medicine (MindMed) Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
MNMD Solvency Score
Solvency Due Diligence
Mind Medicine (MindMed) Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
Mind Medicine (MindMed) Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MNMD Price Targets Summary
Mind Medicine (MindMed) Inc
According to Wall Street analysts, the average 1-year price target for
MNMD
is 24.48 USD
with a low forecast of 16.16 USD and a high forecast of 57.75 USD.
Dividends
Current shareholder yield for MNMD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?